Description
QuickVue Influenza A+B Procedure Card
QuickVue Influenza A+B Procedural Bulletin
QuickVue Influenza A+B FAQ
QuickVue Influenza A+B CLIA Package Insert
Unit: 1 Box (25 Tubes & Swabs)
Regulatory Status: CLIA Waived
Contents: Individually Packaged Test Strips (25): Mouse monoclonal anti-influenza A and anti-influenza B antibodies; Reagent Solution (25): Vials with 340 µL of salt solution; Reagent Tubes (25): Lyophilized buffer with detergents and reducing agents; Disposable Pipettes (25); Sterile Nasal Swabs (25); Positive Influenza Type A Control Swab (1): Swab is coated with non-infectious recombinant influenza A antigen; Positive Influenza Type B Control Swab (1): Swab is coated with non-infectious recombinant influenza B antigen; Negative Control Swab (1): Swab is coated with heat-inactivated, non-infectious Streptococcus C antigen; Package Insert (1); Procedure Card (1)
Sample Type: Nasal Swab, Nasopharyngeal Swab
Storage Requirements: 59° – 86° F (Room Temp)
The QuickVue Influenza A+B Test detects and differentiates influenza type A and type B antigens directly from nasal swab and nasopharyngeal swab specimens. A single sample can be used to run both the QuickVue Influenza A+B Test with results in just 10 minutes.
Key Features:
- Identifies and differentiates both influenza Type A or B in positive samples
- Results approx. 10 minutes or sooner
- Most patients tested can be diagnosed and treated in just one visit
- Accurate detection with nasal/nasopharyngeal swab samples:
- 81.5% PPA and 97.8% NPA for type A
- 80.9% PPA and 99.1% NPA for type B
- 3 steps, 1 reagent, 90 seconds hands-on time
- Each kit contains everything needed to test, including foam-tipped nasal
swabs and Positive and Negative Controls - 24-month shelf life from date of manufacture.
